Navigation Links
Unisense FertiliTech to Present Large Scale Time-lapse Data Analysis to Improve IVF Treatment

AARHUS, Denmark, July 4, 2013 /PRNewswire/ --

Unisense FertiliTech, world leader in time-lapse technology for IVF announce they will present a large scale analysis of embryo development variables which are linked to implantation potential at the European Society of Human Reproduction and Endocrinology (ESHRE) in London July 7th until 10th.  These results will be presented at the Unisense FertiliTech exhibit.


Many clinics using the EmbryoScope™ time-lapse system provide information about embryo development and clinical treatment outcome to Unisense FertiliTech´s database. This database is the largest of its kind and contains detailed information on embryo development characteristics in relation to implantation and successful pregnancy.  

Based on an agreement with 40 clinics comprising 12,000 transferred embryos, a detailed analysis of 8,000 embryos with known implantation outcome was performed.  The analysis revealed clear variables, which could be used to help select better embryos for day 2, 3 or 5 transfer. Furthermore, the strength of the aneuploidy risk algorithm, recently reported by the CARE Fertility group in the journal RBMonline (Campbell et al, Reprod.Biomed. Online 2013 May; 26(5):477-85.) was tested against a large dataset and it confirmed the findings.  

Bjørn Molt Petersen and Mette Lægdsmand, data analysis experts at FertiliTech, state "Although this analysis appears to show convincing trends that are linked to embryo development potential, the analysis also reveals the impact of different culture conditions and practices between clinics. This means that the actual criteria for good embryo quality needs to be individually validated prior to use".  

Unisense FertiliTech who celebrates 10 years in developing innovative technologies to improve embryo selection in the IVF laboratory has developed and manufactures the EmbryoScope™ time-lapse system.  The system was cleared for clinical use in Europe in 2009 and is the only time-lapse system which is FDA cleared for clinical use in the USA.  The technology is used in routine clinical practice by more than 275 clinics worldwide and has been used in approximately 60,000 treatment cycles. It is estimated that more than 10,000 babies have been born using the EmbryoScope™ system.  

In order to allow clinics to utilize the full potential of time-lapse technology, Unisense FertiliTech continues to develop embryo analysis software to improve outcomes in IVF.   Chief Scientific Officer Niels Birger Ramsing states "very early on, we recognized the need for software tools which will allow clinics to customize their own evaluation models in their clinics, that is why we are at the forefront of delivering such tools to help our customers make the best decisions".

About Unisense FertiliTech A/S:

Unisense FertiliTech A/S was founded in 2003 to develop technology to improve human embryo assessment in assisted reproduction. Unisense FertiliTech has developed, and manufactures the EmbryoScope™ time- lapse system, facilitating improved IVF treatment, flexible work routines and effective communication through comprehensive documentation of embryo development and evolving improvements in selection. The System is FDA 510(k) cleared and CE marked as a Class II medical device.

Our Mission is to help infertile couples achieve their dream of parenthood through development of novel technology, quantification and digitized documentation. "The Vision to Conceive"

Unisense FertiliTech A/S

SOURCE Unisense Fertilitech A/S
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Unisense FertiliTech A/S Secures an Additional 20 Million USD in New Capital Investment
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
4. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
6. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
7. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
8. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
9. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
10. PRA Expert to Present at Pharmacovigilance Conference
11. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
Post Your Comments:
(Date:10/8/2015)... Oct. 8, 2015  Sorrento Therapeutics, Inc. (NASDAQ: ... treatments for cancer and associated pain, announced today that ... be presenting at the Aegis Capital Corporation 2015 ... :Event:Aegis Capital Corporation 2015 Growth ConferenceDate:Friday, October 9, ... Encore @ The Wynn in Las Vegas, NV ...
(Date:10/8/2015)... Celemics, a global pioneer of personalized medicine ... market with the establishment of Celemics America, Inc. ... Europe , has secured itself in the global ... sample preparation for DNA sequencing and genetic testing.  Next ... genetic testing more accurately, quickly, and cost effectively than ...
(Date:10/8/2015)... Del. , Oct. 8, 2015  Today, ... CRISPR-Cas technologies for genome editing, jointly announced a ... and Caribou have cross-licensed their respective patent portfolios, with ... technology applications in major row crops, and non-exclusive ... --> --> ...
(Date:10/8/2015)... , Oct. 8, 2015  Sigma-Aldrich Corporation ... Cerilliant ® brand within its Applied Diagnostics ... bile acid reference standards product line with ten ... routinely tested bile acids and their stable-labeled internal ... consist of lithocholic acid, taurocholic acid and native ...
Breaking Biology Technology:
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), ... ) focused on bringing the life saving ... said today that Matthew Schissler, founder and CEO, in ... Company is very close to becoming cash flow positive.The ...
... CRY ), a biomaterials, medical device and tissue processing company, ... results will be released on Thursday, February 19, 2009. ... at 10:00 a.m. Eastern Time, February 19, 2009, to discuss ... by Steven G. Anderson, president and CEO of CryoLife, Inc.To ...
... INCHEON, South Korea, Feb. 5 The Centers for ... Korean,biopharmaceutical company, have signed a Letter of Intent to ... protect people exposed to,the rabies virus. , ... rabies is a two-step procedure.,First, rabies immune globulin (RIG) ...
Cached Biology Technology:
(Date:9/30/2015)... , Sept. 30, 2015  The global glucose monitoring device ... 2015. So says a new report on the industry from ... segment dominate the market, followed by continuous glucose monitoring and ... on the market for these products in its latest report, ... , ...
(Date:9/29/2015)... 2015  iDAvatars is excited to be named one of ... market. The official announcement was recently made at an invite-only ... San Francisco , where iDAvatars presented a ... Watson. "It is both an honor and a ... bring to market the cognitive power of IBM Watson in ...
(Date:9/28/2015)... 2015  The monitoring of vital signs, such ... is an essential component of patient assessment. Changes ... in a patient,s condition. However, in general care ... taken during routine observation rounds only once every ... between these observation rounds, the warning signs can ...
Breaking Biology News(10 mins):
... it can damage blood vessels and increase the risk of ... he can thin the human blood by subjecting it to ... physics at Temple University, has pioneered the use of electric ... engines and pipelines. Now, he is using the same magnetic ...
... coastal areas in Africa can rarely utilise their entire fishing ... near the coast. Research carried out by economist Kofi Vondolia ... of fish stocks is significant to fish management. ... allows foreign fishing fleets to utilise the zones further out ...
... the Virginia Institute of Marine Science (VIMS) shows that jellyfish ... altering marine food webs by shunting food energy from fish ... frequency of jellyfish blooms in coastal and estuarine waters around ... impact on marine food webs is likely to increase into ...
Cached Biology News:
... V, is used for agitation and mixing applications ... and destaining of gels and blots, and Southern ... rpm) and can handle a maximum load of ... 29 x 21 cm platforms covered with nonslip ...
... (3-ethylbenzthiazoline-6-sulfonic Acid) Clear to very pale ... H 2 O 2 in a citrate ... that is soluble, safe, convenient and has good ... intense blue-green color that can be measured at ...
Biology Products: